Ann Surg Treat Res.  2022 Feb;102(2):90-99. 10.4174/astr.2022.102.2.90.

Preventive effect of biodegradable stents on biliary stricture and fibrosis after biliary anastomosis in a porcine model

• Kwon CI
• Choi SH
• Kim KS
• Moon JP
• Park S
• Jeon J
• Kim G
• Jang JY
• Sung MJ
• Ko KH
• Son JS

• KMID: 2525446
• DOI: http://doi.org/10.4174/astr.2022.102.2.90

Abstract

Purpose
The current drain tubes for preventing surgically biliary anastomotic stricture are not naturally and easily removed. If a drain tube using biodegradable material is easily available and the degradation time of the tube is well controlled, surgical anastomotic stricture and fibrosis could be prevented. The aim of this animal study was to evaluate the preventive effect of novel biodegradable stents (BS) on biliary stricture and fibrosis after duct-to-duct (DD) biliary anastomosis.
Methods
Ten mini-pigs were allocated to the control group (n = 5) and or the stent group (n = 5). The common bile duct was exposed through surgical laparotomy and then resected transversely. In the stent group, a 4-mm or 6-mm polydioxanone/ magnesium sheath-core BS was inserted according to the width of the bile duct, followed by DD biliary anastomosis. In the control group, DD biliary anastomosis was performed without BS insertion.
Results
In the stent group, stents were observed without deformity for up to 4 weeks in all animals. Eight weeks later, histopathologic examination revealed that the common bile duct of the anastomosis site was relatively narrower in circumference in the control group compared to the stent group. The degree of fibrosis in the control group was more marked than in the stent group (3.84 mm vs. 0.68 mm, respectively; P < 0.05).
Conclusion
Our study showed that novel BS maintained their original shape and radial force for an adequate time and then disappeared without adverse events. The BS could prevent postoperative complications and strictures after DD biliary anastomosis.

Keyword

Anastomosis; Bile ducts; Biliary stents; Biodegradable; Stents

Figure

• 

  Fig. 1 Shape of the biodegradable filaments and stents. (A, B) Scanning electron microscopic images of polydioxanone/magnesium (PDO/Mg) sheath-core monofilaments (A, surface [×50]; B, cross-section [×180]). (C) Prototype biodegradable stents were made using the cross-and-hook knitting handmade method.

• 

  Fig. 2 Trimming of the common bile duct (CBD) in the swine. (A) Exposure and isolation of the CBD. (B) Transverse cutting of the CBD. (C) Measuring the inner diameter of the transected CBD using calipers. (D) Measuring the outer diameter of the transected CBD using calipers.

• 

  Fig. 3 Process of duct-to-duct anastomosis in the swine. (A, B) Control group. Duct-to-duct anastomosis with posterior wall continuous sutures and anterior wall interrupted suture using 6-0 polypropylene monofilaments (Prolene; Ethicone, Inc., Somerville, NJ, USA) without biodegradable stent (BS) insertion. (C, D) Stent group. After posterior wall continuous suture, a 4-mm or 6-mm polydioxanone/magnesium sheath-core BS was inserted into the transected CBD. Then, the anterior wall was closed by interrupted sutures.

• 

  Fig. 4 Process of cholecystectomy in the swine. (A) Detachment of the gallbladder from the liver bed. (B) Removal of the gallbladder dividing the cystic duct. (C) Gross appearance of cholecystectomy specimen.

• 

  Fig. 5 Autopsy findings. (A) Distended intestine due to major bleeding. (B) Dark red mucosal changes in the large intestine due to ischemic changes.

• 

  Fig. 6 Fluoroscopic tracking images of the inserted biodegradable stents. The biodegradable stents were observed without deformity until 4 weeks in all swine. However, all biodegradable stents are deformed or disappeared at 6 weeks. The length of the red ladder marks represents the length of the gold marks attached to both ends of the stents without deformity. The red arrow represents the gold marks that partially existed due to the degradation of the stents at 6 weeks.

• 

  Fig. 7 Histopathologic images. (A) Gross images of the common bile ducts. The circumferences of the duct-to-duct anastomosis area (red arrows) in the stent group (specimens 2, 4, 6, 8, and 10) are wider than those in the control group (specimens 1, 3, and 7). (B) Microscopic images of the duct-to-duct anastomosis area. Masson’s trichrome staining of paraffin-embedded tissue revealed much thicker fibrosis (blue color in collagen accumulation) in the control group than in the stent group (×40).

Reference

1. Gondolesi GE, Varotti G, Florman SS, Muñoz L, Fishbein TM, Emre SH, et al. Biliary complications in 96 consecutive right lobe living donor transplant recipients. Transplantation. 2004; 77:1842–1848. PMID: 15223901.

2. Dulundu E, Sugawara Y, Sano K, Kishi Y, Akamatsu N, Kaneko J, et al. Duct-to-duct biliary reconstruction in adult living-donor liver transplantation. Transplantation. 2004; 78:574–579. PMID: 15446317.

3. Yazumi S, Yoshimoto T, Hisatsune H, Hasegawa K, Kida M, Tada S, et al. Endoscopic treatment of biliary complications after right-lobe living-donor liver transplantation with duct-to-duct biliary anastomosis. J Hepatobiliary Pancreat Surg. 2006; 13:502–510. PMID: 17139423.

4. Tsujino T, Isayama H, Sugawara Y, Sasaki T, Kogure H, Nakai Y, et al. Endoscopic management of biliary complications after adult living donor liver transplantation. Am J Gastroenterol. 2006; 101:2230–2236. PMID: 16952286.

5. Chok KS, Lo CM. Biliary complications in right lobe living donor liver transplantation. Hepatol Int. 2016; 10:553–558. PMID: 26932842.

6. Akamatsu N, Sugawara Y, Hashimoto D. Biliary reconstruction, its complications and management of biliary complications after adult liver transplantation: a systematic review of the incidence, risk factors and outcome. Transpl Int. 2011; 24:379–392. PMID: 21143651.

7. Sharma S, Gurakar A, Jabbour N. Biliary strictures following liver transplantation: past, present and preventive strategies. Liver Transpl. 2008; 14:759–769. PMID: 18508368.

8. Liu CL, Fan ST, Lo CM, Wei WI, Chan SC, Yong BH, et al. Operative outcomes of adult-to-adult right lobe live donor liver transplantation: a comparative study with cadaveric whole-graft liver transplantation in a single center. Ann Surg. 2006; 243:404–410. PMID: 16495707.

9. Gómez CM, Dumonceau JM, Marcolongo M, de Santibañes E, Ciardullo M, Pekolj J, et al. Endoscopic management of biliary complications after adult living-donor versus deceased-donor liver transplantation. Transplantation. 2009; 88:1280–1285. PMID: 19996927.

10. Samstein B, Smith AR, Freise CE, Zimmerman MA, Baker T, Olthoff KM, et al. Complications and their resolution in recipients of deceased and living donor liver transplants: findings from the A2ALL Cohort Study. Am J Transplant. 2016; 16:594–602. PMID: 26461803.

11. Kimura W. Pancreaticojejunal anastomosis, using a stent tube, in pancreaticoduodenectomy. J Hepatobiliary Pancreat Surg. 2009; 16:305–309. PMID: 19350197.

12. Azumi Y, Isaji S. Stented pancreaticojejunostomy (with video). J Hepatobiliary Pancreat Sci. 2012; 19:116–124. PMID: 22076668.

13. Levy MJ, Chari S, Adler DG, Clain JE, Gostout CJ, Harewood GC, et al. Complications of temporary pancreatic stent insertion for pancreaticojejunal anastomosis during pancreaticoduodenectomy. Gastrointest Endosc. 2004; 59:719–724. PMID: 15114323.

14. Zhou Y, Yang C, Wang S, Chen J, Li B. Does external pancreatic duct stent decrease pancreatic fistula rate after pancreatic resection?: a meta-analysis. Pancreatology. 2011; 11:362–370. PMID: 21876365.

15. Xiong JJ, Altaf K, Mukherjee R, Huang W, Hu WM, Li A, et al. Systematic review and meta-analysis of outcomes after intraoperative pancreatic duct stent placement during pancreaticoduodenectomy. Br J Surg. 2012; 99:1050–1061. PMID: 22622664.

16. Tashiro H, Ogawa T, Itamoto T, Ushitora Y, Tanimoto Y, Oshita A, et al. Synthetic bioabsorbable stent material for duct-to-duct biliary reconstruction. J Surg Res. 2009; 151:85–88. PMID: 18674784.

17. Tanimoto Y, Tashiro H, Mikuriya Y, Kuroda S, Hashimoto M, Kobayashi T, et al. Radiopaque biodegradable stent for duct-to-duct biliary reconstruction in pigs. Langenbecks Arch Surg. 2016; 401:513–517. PMID: 27138018.

18. Aikawa M, Miyazawa M, Okada K, Toshimitsu Y, Okamoto K, Akimoto N, et al. Development of a novel reflux-free bilioenteric anastomosis procedure by using a bioabsorbable polymer tube. J Hepatobiliary Pancreat Sci. 2010; 17:284–290. PMID: 19812888.

19. Itoi T, Kasuya K, Abe Y, Isayama H. Endoscopic placement of a new short-term biodegradable pancreatic and biliary stent in an animal model: a preliminary feasibility study (with videos). J Hepatobiliary Pancreat Sci. 2011; 18:463–467. PMID: 21170555.

20. Laukkarinen J, Sand J, Leppiniemi J, Kellomäki M, Nordback I. A novel technique for hepaticojejunostomy for nondilated bile ducts: a purse-string anastomosis with an intra-anastomotic biodegradable biliary stent. Am J Surg. 2010; 200:124–130. PMID: 20074696.

21. Shi J, Lv Y, Yu L, Zhang B, Zhang X, Fan C, et al. Interest of a new biodegradable stent coated with paclitaxel on anastomotic wound healing after biliary reconstruction. Eur J Gastroenterol Hepatol. 2013; 25:1415–1423. PMID: 23669325.

22. Kwon CI, Son JS, Kim KS, Moon JP, Park S, Jeon J, et al. Mechanical properties and degradation process of biliary self-expandable biodegradable stents. Dig Endosc. 2021; 33:1158–1169. PMID: 33319399.

23. Innes JT, Ferrara JJ, Carey LC. Biliary reconstruction without transanastomotic stent. Am Surg. 1988; 54:27–30. PMID: 3337479.

24. Bismuth H, Franco D, Corlette MB, Hepp J. Long term results of Roux-en-Y hepaticojejunostomy. Surg Gynecol Obstet. 1978; 146:161–167. PMID: 622659.

25. Janousek L, Maly S, Oliverius M, Kocik M, Kucera M, Fronek J. Bile duct anastomosis supplied with biodegradable stent in liver transplantation: the initial experience. Transplant Proc. 2016; 48:3312–3316. PMID: 27931575.

26. Nordback I, Räty S, Laukkarinen J, Järvinen S, Piironen A, Leppiniemi J, et al. A novel radiopaque biodegradable stent for pancreatobiliary applications: the first human phase I trial in the pancreas. Pancreatology. 2012; 12:264–271. PMID: 22687383.